Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: A prospective, randomized, double-masked, active-controlled, three-period crossover pilot study

Autor: Sonty, Sriram, Mundorf, Thomas K., Stewart, Jeanette A., Stewart, William C.
Zdroj: In Clinical Therapeutics October 2009 31(10):2063-2071
Databáze: ScienceDirect